A Randomized Phase II Trial of Two Dose Schedules of Carboplatin/Paclitaxel/Cetuximab in Stage IIIB/IV Non-Small Cell Lung Cancer.
Phase of Trial: Phase II
Latest Information Update: 13 Apr 2010
At a glance
- Drugs Carboplatin; Cetuximab; Paclitaxel
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Sponsors ImClone Systems
- 31 Aug 2018 Biomarkers information updated
- 13 Oct 2009 Actual initiation date changed from Dec 2004 to Nov 2004 as reported by ClinicalTrials.gov.
- 01 Oct 2008 Actual number of patients enrolled was 160 according to Clinicaltrials.gov record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History